PT3279210T - Péptido com atividade anticancerígena, composição farmacêutica e composição de suplementos alimentares para prevenção e tratamento do cancro, ambos os quais contêm o mesmo ingrediente ativo - Google Patents
Péptido com atividade anticancerígena, composição farmacêutica e composição de suplementos alimentares para prevenção e tratamento do cancro, ambos os quais contêm o mesmo ingrediente ativoInfo
- Publication number
- PT3279210T PT3279210T PT167734086T PT16773408T PT3279210T PT 3279210 T PT3279210 T PT 3279210T PT 167734086 T PT167734086 T PT 167734086T PT 16773408 T PT16773408 T PT 16773408T PT 3279210 T PT3279210 T PT 3279210T
- Authority
- PT
- Portugal
- Prior art keywords
- peptide
- preventing
- active ingredient
- treating cancer
- dietary supplement
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000004480 active ingredient Substances 0.000 title 1
- 230000001093 anti-cancer Effects 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 235000015872 dietary supplement Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Pediatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20150045480 | 2015-03-31 | ||
| KR1020160033118A KR101841339B1 (ko) | 2015-03-31 | 2016-03-21 | 항암 활성을 갖는 펩티드, 이를 유효성분으로 함유하는 암 예방 및 치료용 약학 조성물 및 건강기능식품 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3279210T true PT3279210T (pt) | 2020-04-29 |
Family
ID=57146316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT167734086T PT3279210T (pt) | 2015-03-31 | 2016-03-29 | Péptido com atividade anticancerígena, composição farmacêutica e composição de suplementos alimentares para prevenção e tratamento do cancro, ambos os quais contêm o mesmo ingrediente ativo |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10611797B2 (pt) |
| EP (1) | EP3279210B1 (pt) |
| KR (1) | KR101841339B1 (pt) |
| CN (1) | CN107624116B (pt) |
| ES (1) | ES2793048T3 (pt) |
| PT (1) | PT3279210T (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101926918B1 (ko) * | 2016-08-30 | 2018-12-07 | 한양대학교 산학협력단 | 항암 활성을 갖는 펩티드, 이를 유효성분으로 함유하는 암 예방 및 치료용 약학 조성물 및 건강기능식품 조성물 |
| EP4005583A4 (en) * | 2019-04-01 | 2023-04-26 | Industry - University Cooperation Foundation Hanyang University | ANTI-CANCER AGAINST PEPTIDE-BASED CP2C |
| KR102261371B1 (ko) * | 2019-04-01 | 2021-06-08 | 한양대학교 산학협력단 | CP2c 표적 펩티드 기반 항암제 |
| KR102355987B1 (ko) * | 2020-02-05 | 2022-01-26 | 한양대학교 산학협력단 | 불포화 지방산 결합 CP2c 표적 펩타이드 기반 항암제 |
| KR102457344B1 (ko) * | 2020-06-22 | 2022-10-24 | 건국대학교 글로컬산학협력단 | 항암 펩티드와 결합된 항원결합단편 플랫폼 |
| KR102528947B1 (ko) * | 2020-07-09 | 2023-05-08 | 한양대학교 산학협력단 | Nlrx1 단백질의 lrr 도메인을 기반으로 하는 신경계 자가면역질환 예방 또는 치료용 조성물 |
| KR102475101B1 (ko) | 2020-08-26 | 2022-12-07 | 주식회사 씨쥐케이바이오파마엘티디 | 다양한 미생물 및 항생제 내성균에 항생 효과를 갖는 항생 펩타이드 |
| CN112402626B (zh) * | 2020-11-26 | 2023-05-02 | 中国人民解放军陆军军医大学第二附属医院 | 一种靶向肿瘤的生物伪装纳米递药系统及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| US9283244B2 (en) * | 2010-04-01 | 2016-03-15 | Virginia Commonwealth University | Treatment of cancer by inhibiting activity or expression of late SV-40 factor |
| CN103347520A (zh) * | 2010-10-13 | 2013-10-09 | 波士顿大学管理委员会 | 用作癌症化学治疗的晚期sv40因子（lsf）的抑制剂 |
| CN102600489A (zh) * | 2012-02-24 | 2012-07-25 | 南方医科大学南方医院 | 含iRGD序列的多肽放射性药物 |
| WO2013127288A1 (zh) * | 2012-02-27 | 2013-09-06 | 中国人民解放军军事医学科学院毒物药物研究所 | 抗hiv-1多肽及其用途 |
| WO2016097313A1 (en) * | 2014-12-19 | 2016-06-23 | Ablynx N.V. | Cysteine linked nanobody dimers |
| RU2571551C1 (ru) * | 2015-04-16 | 2015-12-20 | Закрытое акционерное общество "ПЕПТЕК" | Специфическая сочетанная терапия злокачественных опухолей цитостатиком и его модификатором |
-
2016
- 2016-03-21 KR KR1020160033118A patent/KR101841339B1/ko active IP Right Grant
- 2016-03-29 ES ES16773408T patent/ES2793048T3/es active Active
- 2016-03-29 US US15/563,533 patent/US10611797B2/en active Active
- 2016-03-29 PT PT167734086T patent/PT3279210T/pt unknown
- 2016-03-29 EP EP16773408.6A patent/EP3279210B1/en active Active
- 2016-03-29 CN CN201680029185.6A patent/CN107624116B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3279210A1 (en) | 2018-02-07 |
| US10611797B2 (en) | 2020-04-07 |
| EP3279210A4 (en) | 2018-08-15 |
| KR20160117198A (ko) | 2016-10-10 |
| KR101841339B1 (ko) | 2018-03-22 |
| ES2793048T3 (es) | 2020-11-12 |
| CN107624116A (zh) | 2018-01-23 |
| US20180086788A1 (en) | 2018-03-29 |
| CN107624116B (zh) | 2021-08-31 |
| EP3279210B1 (en) | 2020-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3279210T (pt) | Péptido com atividade anticancerígena, composição farmacêutica e composição de suplementos alimentares para prevenção e tratamento do cancro, ambos os quais contêm o mesmo ingrediente ativo | |
| EP3263135A4 (en) | Pharmaceutical composition for treating cancer comprising microrna as active ingredient | |
| SG11202106160WA (en) | Pharmaceutical composition for prevention or treatment of cancer comprising weissella cibaria wikim28 as active ingredient | |
| ZA201908241B (en) | N2,n4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer | |
| EP3111931A4 (en) | Pharmaceutical composition for cancer treatment containing gossypol and phenformin as active ingredients | |
| SG11201605868XA (en) | Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient | |
| HK1257615A1 (zh) | 用於治療癌症、含有多酚化合物作為活性成分的藥物組合物 | |
| EP3489252A4 (en) | PEPTIDE WITH ANTI-CANCER EFFECT AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER, FUNCTIONAL FOOD COMPOSITION AND FUNCTIONAL COSMETIC COMPOSITION THEREFORE AS AN ACTIVE SUBSTANCE | |
| HRP20191265T8 (hr) | Supstituirani 2-tiokso-imidazolidin-4-oni i njihovi spiro analozi, aktivni anti-kancerogeni sastojak, farmaceutska kompozicija, medicinski preparat, metoda za liječenje raka prostate | |
| IL272168A (en) | The compositions for increasing the bioavailability of drugs, additives and substances for ingestion | |
| PH12016501527B1 (en) | Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient | |
| EP3336100A4 (en) | PEPTIDE WITH EFFECT FOR PREVENTING OR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM THEREFOR AS AN ACTIVE SUBSTANCE | |
| IL268224A (en) | A pharmaceutical compound for the prevention and treatment of pancreatic cancer, containing GOSSYPOL and PHENFORMIN as active ingredients | |
| MX2018005439A (es) | Compuestos oxadiazoespiricos para el tratamiento del abuso y la adiccion a las drogas. | |
| EP3610866A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CANCER, CONTAINING A MALATE-ASPARTATE SHUTTLE INHIBITOR AND ANTI-CANCER DRUG AS ACTIVE SUBSTANCES | |
| GB2579480B (en) | Composition for preventing or treating cancer containing Triazolopyridine-based derivative as active ingredient | |
| EP3398608A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER OR CANCER METASTASES WITH PSTL1-PRTEIN AS AN ACTIVE SUBSTANCE | |
| EP2910246A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER WITH ENOBLOCK AS AN ACTIVE SUBSTANCE | |
| SG11202106163RA (en) | Pharmaceutical composition for prevention or treatment of cancer comprising lactobacillus sakei wikim30 as active ingredient | |
| EP3417869A4 (en) | COMPOSITION CONTAINING RHIZOMA PHRAGMITIS EXTRACT AS AN ACTIVE INGREDIENT FOR PREVENTING, IMPROVING OR TREATING DISEASES AFFECTED BY ANTI-CANCER AGENT'S SECONDARY EFFECT | |
| EP3053601A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CANCER CONTAINING THE CYB5R3 GENE OR PROTEIN AS AN ACTIVE SUBSTANCE | |
| HK1251988A1 (zh) | 包含作為活性成分的色甘酸或其藥學上可接受的鹽的用於預防和治療肝臟疾病的藥物組合物 |